This large, prospective, observational study shows that a direct switch from NPH insulin to Gla-300 results in a significant improvement in diabetes control (as reflected in HbA1c) and a reduction of the number of patients experiencing ≥1 hypoglycaemia, without an increase in body weight, which comes at the cost of only a moderate increase in insulin dose. This evidence concerns the gene INS and diabetes mellitus.